Abbvie Inc (NYSE:ABBV)
| 109.37 BATS BZX Real-Time Price As of 3:24pm ET |  +0.86 / +0.80%Today’s Change | 79.11 Today|||52-Week Range 121.53 | +2.07% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 108.50 |
| Today’s open | 108.83 |
| Day’s range | 108.23 - 109.55 |
| Volume | 3,036,006 |
| Average volume (3 months) | 6,799,000 |
| Market cap | $192.9B |
Data as of 3:24pm ET, 10/26/2021
Growth & Valuation
| Earnings growth (last year) | -48.39% |
| Earnings growth (this year) | +19.25% |
| Earnings growth (next 5 years) | +4.40% |
| Revenue growth (last year) | +37.69% |
| P/E ratio | 29.6 |
| Price/Sales | 3.91 |
| Price/Book | 14.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | +0.54 | +0.87% |
| NVSNovartis | +1.42 | +1.70% |
| NVONovo Nordisk | +1.29 | +1.22% |
| MRKMerck | +0.43 | +0.53% |
Data as of 3:24pm ET, 10/26/2021
Financials
| Next reporting date | October 29, 2021 |
| EPS forecast (this quarter) | $3.21 |
| Annual revenue (last year) | $45.8B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 9.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
